The heart has been recognized as a major target of thyroid hormone action. Our study investigates both the regulation of cardiac-specific genes and contractile behavior of the heart in the presence of a mutant thyroid hormone receptor ␤1 (T 3 R␤1-⌬337T) derived from the S kindred. The mutant receptor was originally identified in a patient with generalized resistance to thyroid hormone. Cardiac expression of the mutant receptor was achieved by a transgenic approach in mice. As the genes for myosin heavy chains (MHC␣ and MHC␤) and the cardiac sarcoplasmic reticulum Ca 2ϩ adenosine triphosphatase (SERCA2) are known to be regulated by T 3 , their cardiac expression was analyzed. The messenger RNA levels for MHC␣ and SERCA2 were markedly down-regulated, MHC␤ messenger RNA was up-regulated. Although T 3 levels were normal in these animals, this pattern of cardiac gene expression mimics a hypothyroid phenotype. Cardiac muscle contraction was significantly prolonged in papillary muscles from transgenic mice. The electrocardiogram of transgenic mice showed a substantial prolongation of the QRS interval. Changes in cardiac gene expression, cardiac muscle contractility, and electrocardiogram are compatible with a hypothyroid cardiac phenotype despite normal T 3 levels, indicating a dominant negative effect of the T 3 R␤ mutant. (Endocrinology 140: [897][898][899][900][901][902] 1999) T HE HEART is a major target for thyroid hormone action, and patients with hypo-or hyperthyroidism show marked changes in heart rate and cardiac contractility (1-5). Hypothyroidism is characterized by decreased heart rate and delayed diastolic relaxation, whereas in hyperthyroidism the opposite changes occur (6). Normalization of thyroid hormone levels in hypo-or hyperthyroid patients returns cardiac function to the baseline. Changes in cardiac function have also been reported in patients with the resistance to thyroid hormone syndrome (RTH). In particular the pulse wave arrival time is delayed in some patients, indicating a hypothyroid contractile phenotype (7). In contrast, in some other patients with RTH, tachycardia occurs. Molecular analysis of patients with RTH revealed mutations in the functionally relevant domains of the thyroid hormone receptor ␤ (T 3 R␤) isoform. Point mutations and deletions in the ligandbinding domain were found to render T 3 R␤ nonresponsive to T 3 binding (8, 9). The mutant receptors are still capable of binding to DNA and interacting with retinoid X receptor, which leads to interference with T 3 signaling by normal T 3 R␣ and -␤ receptors, resulting in a dominant negative action. In one kindred with RTH, designated the S family, resulting from a deletion of threonine at position 337, a single patient was found to be homozygous for the T 3 R␤ mutant (10). This child showed profound resistance to thyroid hormone and developed a hyperactive syndrome accompanied by marked tachycardia contributing to the child's early demise. To explore in further detail the influence that the expression of a mutant T 3 R␤ in cardiac myocytes has on cardiac gene expression and the cardiac phenotype, we generated transgenic mice with the mutant complementary DNA (cDNA). These were bred for homozygosity and used for all experiments throughout our study. In this mouse model, thyroid hormone levels were normal. However, the expression of myosin heavy chain (MHC) isoforms and the gene coding for the Ca 2ϩ adenosine triphosphatase (ATPase) of the sarcoplasmic reticulum as well as cardiac muscle contractile changes and prolongation of the QRS interval in the electrocardiogram (ECG), resembled a significantly hypothyroid cardiac phenotype. The T 3 R␤ mutant induced changes are described in further detail in this report.
T HE HEART is a major target for thyroid hormone action, and patients with hypo-or hyperthyroidism show marked changes in heart rate and cardiac contractility (1) (2) (3) (4) (5) . Hypothyroidism is characterized by decreased heart rate and delayed diastolic relaxation, whereas in hyperthyroidism the opposite changes occur (6) . Normalization of thyroid hormone levels in hypo-or hyperthyroid patients returns cardiac function to the baseline. Changes in cardiac function have also been reported in patients with the resistance to thyroid hormone syndrome (RTH). In particular the pulse wave arrival time is delayed in some patients, indicating a hypothyroid contractile phenotype (7) . In contrast, in some other patients with RTH, tachycardia occurs. Molecular analysis of patients with RTH revealed mutations in the functionally relevant domains of the thyroid hormone receptor ␤ (T 3 R␤) isoform. Point mutations and deletions in the ligandbinding domain were found to render T 3 R␤ nonresponsive to T 3 binding (8, 9) . The mutant receptors are still capable of binding to DNA and interacting with retinoid X receptor, which leads to interference with T 3 signaling by normal T 3 R␣ and -␤ receptors, resulting in a dominant negative action. In one kindred with RTH, designated the S family, resulting from a deletion of threonine at position 337, a single patient was found to be homozygous for the T 3 R␤ mutant (10) . This child showed profound resistance to thyroid hormone and developed a hyperactive syndrome accompanied by marked tachycardia contributing to the child's early demise. To explore in further detail the influence that the expression of a mutant T 3 R␤ in cardiac myocytes has on cardiac gene expression and the cardiac phenotype, we generated transgenic mice with the mutant complementary DNA (cDNA). These were bred for homozygosity and used for all experiments throughout our study. In this mouse model, thyroid hormone levels were normal. However, the expression of myosin heavy chain (MHC) isoforms and the gene coding for the Ca 2ϩ adenosine triphosphatase (ATPase) of the sarcoplasmic reticulum as well as cardiac muscle contractile changes and prolongation of the QRS interval in the electrocardiogram (ECG), resembled a significantly hypothyroid cardiac phenotype. The T 3 R␤ mutant induced changes are described in further detail in this report.
Materials and Methods

Construction of the transgene
The mutated human (h) T 3 R␤ cDNA, originally obtained from Stephen J. Usala in a pGEM-3 vector, was excised with EcoRI. The mutation (10) is a deletion of a threonine amino acid at position 337 in the hT 3 R␤ and was initially observed in the kindred of the S family. The cDNA coding for the T 3 R␤ mutant was cloned as a EcoRI fragment into the pCAGGS vector (11) . The correct orientation was determined by restriction mapping, and the resulting clone was designated phT 3 R␤S. A schematic drawing of this construct is shown in Fig. 1 . For the generation of transgenic animals, a large amount of plasmid was cleaved with SalI and HindIII, and the resulting fragment was purified. The protocol to generate transgenic mice was described by Hogan (12) . Briefly, the female pronuclei of eggs from superovulated C57BL/6 ϫ BALB/c mice were injected with 1-2 pl of the purified DNA fragment at a concentration of 2 g/ml. The injected eggs were then transferred into the oviduct of pseudopregnant BALB/c mice. Litters were delivered after approximately 20 days gestation.
Analysis of transgenic animals
To verify the success of the transgene integration into the mouse genome, genomic DNA was extracted from tails of 3-week-old mice and subjected to Southern blot analysis. The tail DNA was first digested with ApaI and PstI endonucleases, resolved on an agarose gel, transferred onto a nylon membrane, and then hybridized with a 32 P-labeled PstI/ XbaI fragment encompassing the chicken ␤-actin intron and part of the hT 3 R␤ cDNA (Fig. 1) . If the transgene was inserted into the mouse genome, ApaI and PstI digestion would generate a 1579-bp fragment that specifically hybridized to the probe.
To determine the number of copies of the transgene integrated into the genome of the transgenic mice, 0.5-2.0 g genomic DNA were used, previously isolated from the tails of wild-type and homozygous transgenic mice. DNA was ribonuclease treated and bound to a nylon membrane with a slot blot apparatus. The blot was probed with a 220-bp 5Ј-fragment corresponding to the first 70 amino acids of the hT 3 R␤, and the slope of a line, plotting photographic density on the y-axis and DNA concentration on the x-axis, showed that there was one copy of the transgene integrated into one chromosome of the transgenic mice.
Blood from wild-type and transgenic mice was collected to determine the content of circulating total T 3 and T 4 hormones. Serum analysis was performed at the University of California-San Diego Medical Center/ Clinical Chemistry Laboratory. In addition, TSH levels were determined by Dr. Forrest's laboratory (Mt. Sinai Hospital, New York, NY) (13) .
RNA isolation and Northern blot analysis
Isolation of tissue RNA was performed as described by Chomczynski and Sacchi (14) . For electrophoresis, Northern transfer, and hybridization, the protocol was as described previously (15) . RNA was visualized and photographed before transfer to Magna Graph membranes (Micron Separations Inc., Westboro, MA) overnight in 10 ϫ SSC (standard saline citrate). Membranes were subsequently baked at 80 C in a vacuum oven for 1-2 h. The probes used to study gene transcription are specified as follows. To characterize the hT 3 R␤ transgene expression, a full-length rat T 3 R␣ cDNA was used. Restriction fragments of cDNAs for SERCA2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were isolated and used to characterize the expression of these genes in the heart of wild-type and transgenic animals. Highly specific oligonucleotides complementary to the MHC␣ or MHC␤ messenger RNA (mRNA) served to detect their respective mRNA on Northern blots.
The oligonucleotides were labeled using terminal deoxynucleotide transferase and [␣-
32 P]deoxy-CTP. SERCA2, rat T 3 R␣, and GAPDH fragments were labeled with [␣-
32 P]deoxy-CTP by a random hexamer priming protocol (16) to a specific activity of about 5 ϫ 10 8 cpm/g and hybridized to Northern filters as described previously in a 50% formamide-containing solution at 42 C overnight. Filters were subsequently washed to a stringency of 0.5 ϫ SSC (1 ϫ SSC ϭ 0.15 m NaCl and 0.015 m sodium citrate, pH 7.0)-0.1% SDS at 55 C.
Isolated papillary muscle experiments
Contractile parameters of papillary muscles were measured as previously described (17) . Briefly, left ventricular papillary muscles from the hearts of six mutant T 3 R␤ mice and eight wild-type mice were excised under oxygenated Tyrode solution (136 mm NaCl, 5.4 mm KCl, 1 mm MgCl 2 , 0.33 mm NaH 2 PO 4 , 10 mm HEPES, and 10 mm glucose, pH 7.40) containing 30 mm 2,3-butanedione monoxime and 2.5 mm CaCl 2 . They were inserted into ⍀-shaped clamps made from strips of platinum foil, tied with 6.0 braided silk suture, and mounted on hooks of platinum wire in a 0.5-ml muscle chamber.
Muscles were perfused with 2.5 mm Ca 2ϩ Tyrode solution at 37 C and stimulated at 2 and 6 Hz through the platinum clamps (5 V, 0.25-msec duration). Force was measured with an isometric force transducer (OPT1L, Scientific Instruments, Heidelberg, Germany) and recorded on a strip chart recorder. Muscles were stretched over 30 -60 min to the length at which active force development was maximal (L max ). Forces [in millinewtons (mN)] were normalized by the muscle cross-sectional areas to yield stresses (in millinewtons per mm 2 ). The cross-sectional area was calculated for each muscle as the ratio of muscle volume (determined by weighing) and muscle length at L max .
The time to peak tension was determined as the time from 10% of tension development to the peak of contraction. Relaxation times RT 50 and RT 90 were determined as the time from the peak of contraction to 50% or 10%, respectively, of the maximum developed stress during relaxation. Data are expressed as the mean Ϯ sem. Statistical comparisons were made using unpaired Student's t tests.
Electrophysiological measurements in mouse heart
For ECG measurements, 6 transgene positive mice, 10 hypothyroid mice, and 5 age-matched normal mice were analyzed. Hypothyroidism was established in the mice by feeding the animals iodine-deficient, 0.15% 5-propyl-2-thiouracil-containing food pellets (Harlan Teklad, Madison, WI) for 4 weeks. The described procedures were performed in accordance with the guidelines established by the committee on animal research at the University of California-San Diego. When mice were sedated after ip injection of a ketamine-xylazine cocktail, they were kept in a supine position by four limb restrainers. Four needles were placed sc on each limb close to the trunk, and an ECG with the leads I, II, III, FIG. 1. Shown is the plasmid from which a SalI/HindIII fragment (sites underlined) was cleaved that was subsequently purified and injected into blastocysts to generate transgenic animals. The vector backbone is derived from a plasmid described by Niwa et al. named pCAGGS. This plasmid provides the cytomegalovirus immediate early enhancer, the chicken ␤-actin promoter containing an intron, as well as a rabbit ␤-globin segment containing a polyadenylation signal and 3Ј-flanking sequences for the transgene. As shown, the cDNA of the dominant negative human thyroid hormone receptor was inserted into the EcoRI sites of the vector. A schematic organization of the receptor domains is drawn on top as an inset and also shows the translation start (indicated with an arrow), the region that encodes the DNA-binding domain, as well as the region to which the thyroid hormone can bind. A small part of the DNA sequence is given, and the naturally occurring mutation is indicated as a deletion of 3 bp within the nucleotide sequence of the receptor.
AVR, AVL, and AVF was obtained. The ECG was acquired with an analog to digital conversion at 2000 Hz on an IBM-compatible 486 computer using Windaq software (Data Instruments, Akron, OH). The following ECG parameters were measured: 1) duration of atrial depolarization (P), 2) duration of excitation progression from the atrium to the ventricle (PQ), 3) duration of depolarization of the ventricles (QRS), and 4) duration of excitation and repolarization of the ventricles (QT). Parameters were measured in each lead and averaged.
Results
Determination of T 3 R␤ mutant transgene copy number and expression
A fragment of the T 3 R␤ mutant vector drawn schematically in Fig. 1 was used to generate transgenic mice. Southern blot analysis of tail DNA digested and hybridized with a hT 3 R␤ probe indicated that we had generated one founder line. It was of interest to determine how many copies of the mutant T 3 R␤ cDNA were integrated in the genome of the transgenic line. Genomic DNA from tails of wild-type and homozygous transgenic animals was prepared and used in a comparative slot blot using a probe from the 5Ј-end of the cDNA that preferentially hybridized with the T 3 R␤ gene. Figure 2 shows the autoradiograph of the slot blot. Densitometric quantification of this slot blot revealed that one copy of the transgene had been integrated into one chromosome.
To determine expression from the T 3 R␤ mutant transgene and the wild-type T 3 R␣ and T 3 R␤ genes, mRNA was prepared from the hearts of transgenic animals and control animals and analyzed by Northern blot. Figure 3 clearly shows that in comparison with transgene-negative mice (lanes 1 and 2) homozygous T 3 R␤ mutant transgenic animals contain a substantial amount of mutant hT 3 R␤ mRNA in their hearts (lanes 3 and 4) . The levels of wild-type T 3 R␣1, T 3 R␣2, and T 3 R␤1 mRNA were not significantly different in the hearts of wild-type and T 3 R␤ mutant mice.
To assess the thyroid status of T 3 R␤ mutant transgenic mice, blood samples were taken, and the concentrations of T 3 , T 4 , and TSH were determined. We found that the levels of thyroid hormones in transgenic animals (T 3 , 66.5 Ϯ 16.6 ng/dl; T 4 , 4.1 Ϯ 1.1 g/dl) were not significantly different compared with those in wild-type animals of the same mouse strain (T 3 , 57.5 Ϯ 12.9 ng/dl; T 4 , 4.5 Ϯ 1.16 g/dl). In addition, TSH levels were similar in wild-type and transgenic mice (wild-type TSH, 56.9 Ϯ 19 ng/ml; T 3 R␤ mutant, 55.4 Ϯ 15 ng/ml). These results are summarized in Table 1 .
Changes in MHC and SERCA2 gene expression in the heart of T 3 R␤ mutant mice
The expression of the different myosin isoforms is markedly influenced by T 3 (18 -20) . Therefore, we analyzed the effect of the mutant T 3 R␤ on MHC and SERCA2 gene expression in transgenic hearts. Northern blots were hybridized with specific probes for MHC␣, MHC␤, and SERCA2 mRNAs. Figure 4A shows the results of a blot that had successively been hybridized with four different probes. The last hybridization was carried out with a probe for GAPDH to confirm equal loading of RNA in each lane. Expression of the MHC␤ gene was markedly increased in transgenic mice compared with that in wild-type mice. Wild-type mice had an undetectable amount of MHC␤ mRNA in a Northern blot and MHC␤ protein in a Coomassie-stained gel (Fig. 4B) . The ventricular homogenates of wild-type and transgenic mice were prepared according to a protocol from J. Robbins and run on a low percentage, glycerol-containing SDS gel followed by Coomassie blue staining (21) . For the MHC␣ gene, the Northern blot showed a 34% reduction in expression of this gene in the heart of T 3 R␤ mutant mice. This number was determined by densitometry of the autoradiograph shown in Fig. 4A .
The enzyme that mediates calcium reuptake from the cytoplasm into the sarcoplasmic reticulum of a muscle cell is the calcium-dependent ATPase of the sarcoplasmic reticulum, termed SERCA2 (22) . The gene encoding this enzyme is   FIG. 2 . Slot blot analysis of wild-type and transgenic tail DNA to determine the number of transgene insertions. In lanes 1 and 2, increasing amounts of wild-type tail DNA were blotted, and in lanes 3 and 4, increasing amounts of tail DNA from transgenic animals were blotted. The amounts of genomic DNA in each row of slots is indicated on the right in micrograms. The filter was then hybridized with a radiolabeled 5Ј-fragment that was T 3 R␤ specific, and the signals on the autoradiograph were scanned to calculate the copy number of T 3 R␤ DNA.
FIG. 3.
Northern blot prepared with mRNA from wild-type mice and transgenic mouse hearts. The blot was probed with a radiolabeled full-length rat T 3 R␣ cDNA. Lanes 1 and 2 show wild-type mRNA, and lanes 3 and 4 show homozygous transgenic mRNA. Three different mRNA species could be detected in the wild-type lanes, and four different species of mRNA were found in the transgenic lanes, the additional fourth corresponding to the expressed transgene. To control for equal loading of RNA, the blot was stripped and hybridized with a probe for GAPDH. regulated by thyroid hormone (23) . To determine whether the presence of the mutant T 3 R␤ receptor influences the expression of the SERCA gene, SERCA2 mRNA levels were determined in transgenic mice by Northern blotting. In hearts from homozygous transgenic animals carrying the T 3 R␤ mutant transgene, SERCA2 was found in 32% lower abundance than that in wild-type animals (Fig. 4A) . It should be noted that heterozygous transgenic animals showed a lesser degree of down-regulation of SERCA2 mRNA than the homozygous animals (data not shown). Upon densitometry of the Northern blot shown in Fig. 4A and another blot (not shown), digital values could be assigned for the intensity of each band. We then performed a statistical analysis on these values from a total of eight transgenic animals and eight wild-type control animals. The MHC␣ values, normalized to the GAPDH values, were set at 1 for controls and were determined to be 0.6575 for transgenics, which was calculated to be a 34% reduction with a P value of 0.022. The SERCA values, also normalized to the GAPDH values, were set at 1 for controls and were determined to be 0.678 for transgenics, which was calculated to be a 32% reduction with a P value of 0.013. As both the SERCA2 down-regulation and the MHC isoform shift could prolong cardiac contraction, papillary muscles were isolated from normal and transgenic mice to perform contractile studies.
Contractile behavior of isolated papillary muscle from T 3 R␤ mutant mice
To characterize the cardiac contractile phenotype of transgenic mice, we determined force development in isolated left ventricular papillary muscles from transgenic and wild-type mice (Fig. 5) . Muscles from mutant thyroid hormone receptor transgenic mice displayed a slight prolongation of time to peak tension, amounting to 12% at 2 Hz stimulation frequency (P Ͻ 0.01) and 10% at 6 Hz stimulation frequency. Relaxation was more markedly impaired. RT 50 increased by 20% at 2 Hz (P Ͻ 0.001) and 21% at 6 Hz (P Ͻ 0.01). The delay of the late phase of relaxation was even more pronounced, as RT 90 was increased by 26% at 2 Hz and 25% at 6 Hz (P Ͻ 0.001).
Although contraction and relaxation of papillary muscles were delayed, active tension development was not affected. Peak stress at 2 Hz was 6.1 Ϯ 1.4 mN/mm 2 in muscles from wild-type mice and 7.2 Ϯ 1.4 mN/mm 2 in muscles from transgenic mice (P ϭ 0.6). At 6 Hz stimulation frequency, peak stresses were 4.0 Ϯ 0.8 mN/mm 2 in wild-type mice and 3.7 Ϯ 0.6 mN/mm 2 in transgenic mice (P ϭ 0.76).
ECG changes in the heart of mutant T 3 R␤ transgenic mice
We compared electrocardiograms obtained from the mutant thyroid hormone receptor transgenic mice with hypothyroid and normal mice. The QRS intervals in transgenic (14.2 Ϯ 1.5 msec) and hypothyroid (12.9 Ϯ 1.6 msec) animals were markedly prolonged compared with that in control animals (10.6 Ϯ 0.4 msec). In addition, the P wave and the PQ interval were markedly prolonged in hypothyroid mice, but not in the mutant T 3 R␤ transgenic mice. These results are summarized in Table 2 . The changes in electrophysiological parameters induced by the expression of a mutant thyroid hormone receptor resemble in part the changes in hypothyroidism (24) .
Discussion
The results of this study demonstrate that expression of the human ⌬337T mutant T 3 R␤ isoform derived from the S fam- ily in the heart of transgenic mice exerts a strong dominant negative effect, leading to a hypothyroid pattern of gene expression, contractile function, and ECG changes. These changes occur despite normal T 3 , T 4 , and TSH levels. A relatively hypothyroid cardiac status and a normal set-point of the pituitary-thyroid feedback loop most likely result from significant expression of the T 3 R␤ mutant in cardiac myocytes, as demonstrated in Northern blots. Expression of the T 3 R␤ mutant occurs most likely at insignificant levels in the pituitary, where it would otherwise impair negative T 3 feedback by lowering TSH production (25) . Strong expression of the mutant T 3 R␤ in cardiac myocytes is in line with the expression pattern of the cytomegalovirus enhancer/chicken ␤-actin promoter, which leads to a strong expression in myocytes, also observed for other transgenes (17) .
Analysis of the expression pattern of the MHC␣ and MHC␤ genes revealed a pattern compatible with a hypothyroid status. The expression of the MHC␤ gene was significantly increased in the hearts of transgenic T 3 R␤ mutant mice. This gene has been shown to be markedly thyroid hormone responsive. The marked increase in its expression in the hypothyroid heart may be in part mediated by increased transcription of the MHC␤ gene (26) .
The presence of a strong negative thyroid hormone response element (TRE) in the promoter of this gene has been postulated (27) , which could explain our findings. The mechanism by which the mutant receptor would up-regulate the MHC␤ promoter is by competition for DNA binding of the wild-type receptor. The wild-type receptor binding to a negative TRE would be associated with hormone and, in contrast to a positive TRE, with a powerful corepressor that is able to silence transcription in an as yet not fully explained fashion. The mRNA levels of the MHC␣ and SERCA2 were reduced in the transgenic animals by 34% and 32%, respectively. These findings can be explained by the presence of positiveacting TREs in the promoter of both the SERCA2 and the MHC␣ gene, which has been reported previously (26, 28 -30) . Analogous to the action on the negative TRE, the mutant receptor would compete with the wild-type receptor to occupy the positive TREs. In this case, however, the mutant receptor cannot associate with the coactivators necessary to stimulate transcription, because of its lack of hormone-binding capacity (31) . Whether the mutant receptor, binding to a positive TRE, is associated with a corepressor that cannot be released because the mutant receptor has impaired hormone binding is not yet clear.
The combined decrease in SERCA2 mRNA and MHC␣ RNA levels and the significant increase in MHC␤ mRNA levels should lead to the cardiac contractile abnormalities that we indeed observed. Cardiac relaxation is influenced by the calcium pump of the sarcoplasmic reticulum (SR), which, during diastole, transports calcium from the cytoplasm into the vesicular structure of the SR, lowering free cytosolic calcium levels. The lower calcium levels result in diminished interaction of the globular head of myosin with actin in the thin filament, accelerating diastolic relaxation. The most marked change in contractile parameters that we observed was a significant delay in cardiac muscle relaxation that is in line with diminished SERCA2 expression. In addition, cardiac contraction was changed, as indicated by the delayed time to peak tension. This parameter is influenced by the speed and magnitude of the calcium increase during the systolic contraction phase, but also by the activity of the myosin ATPase of the globular head of myosin. The higher the myosin ATPase activity, the faster the globular head of myosin moves along the actin thin filament. MHC␣ that forms myosin V1 has a higher myosin ATPase activity than myosin V3 that is composed of two MHC␤ molecules. In addition, a decrease in SERCA activity will lead to decreased filling of the SR, resulting in diminished calcium release during systole that will further contribute to a prolongation of the time needed to reach peak tension. In contrast to the delay in force development during contraction and the prolongation in force decay indicated by delayed relaxation, the maximally developed force was not altered. Therefore, neither alteration in MHC␤ isoform predominance nor the 32% decrease in SERCA2 mRNA levels influenced this parameter.
The ECGs obtained in the T 3 R␤ mutant mice indicated that some electrophysiological parameters of the heart are also compatible with a hypothyroid phenotype similar to changes in contractile behavior. Despite normal thyroid hormone values, the QRS complex in the transgenic animals is markedly prolonged. The detailed molecular mechanisms underlying this change are currently unclear. Thyroid hormoneinduced changes in specific ion channels that may contribute to a prolongation of the action potential have been explored to only a very limited extent. For example, the outward potassium channel, K1T, that is composed of genes coding for the outward rectifying potassium channels, KV 4.2 and KV 4.3, is markedly thyroid hormone responsive (32) . In addition, it has been shown that the mRNA coding for the KV 1.5 ion channel, which contributes to a transient outward and delayed rectifying current, is also markedly decreased by hypothyroidism (33) .
It has been reported that some effects of thyroid hormone on ion channels, such as effects on sodium channels, occur very rapidly and may be mediated by extranuclear effects that are not mediated by T 3 binding to thyroid hormone receptors. Our results are of specific interest related to such a potential extranuclear mechanism. We found marked changes in the expression of T 3 -responsive genes such as MHC isoforms and SERCA2. In addition to hypothyroid contractile and ECG changes in transgenic animals, the T 3 R␤ mutant mice have normal thyroid hormone levels, which strongly argues that the observed changes are mediated by a T 3 receptor-based mechanisms of hormone action. Additional studies in the T 3 R␤ mutant transgenic mice and in T 3 receptor isoform knockout mice that are now becoming available will allow us to explore the nuclear vs. extranuclear effects of T 3 in greater detail.
